Oct 14 (Reuters) - Stella Pharma Corporation PARENT- ONLY EARNINGS ESTIMATES (in billions of yen unless specified) Full Year to Full Year to Mar 31, 2026 Mar 31, 2026 LATEST PREVIOUS FORECAST FORECAST Sales 377 mln 1.01 Operating loss 922 mln loss 348 mln Recurring loss 908 mln loss 345 mln Net loss 911 mln loss 348 mln EPS loss 26.08 yen loss 10.23 yen NOTE - Stella Pharma Corporation. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T